Meningitis Clinical Trials

30 recruitingLast updated: June 18, 2026

There are 30 actively recruiting meningitis clinical trials across 40 countries. Studies span Phase 2, Not Applicable, Phase 3, Phase 4, Phase 1. Top locations include London, United Kingdom, Rio de Janeiro, Brazil, Bethesda, Maryland, United States. Updated daily from ClinicalTrials.gov.


Meningitis Trials at a Glance

30 actively recruiting trials for meningitis are listed on ClinicalTrialsFinder across 6 cities in 40 countries. The largest study group is Phase 2 with 6 trials, with the heaviest enrollment activity in London, Rio de Janeiro, and Bethesda. Lead sponsors running meningitis studies include National Institute of Allergy and Infectious Diseases (NIAID), Hospital Israelita Albert Einstein, and ANRS, Emerging Infectious Diseases.

Browse meningitis trials by phase

Treatments under study

About Meningitis Clinical Trials

Looking for clinical trials for Meningitis? There are currently 12 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Meningitis trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Meningitis clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 30 trials

Recruiting

Etiology, Pathogenesis, and Natural History of Idiopathic CD4+ Lymphocytopenia

Cryptococcal MeningitisWartsIdiopathic CD4+ Lymphocytopenia
National Institute of Allergy and Infectious Diseases (NIAID)950 enrolled1 locationNCT00867269
Recruiting
Not Applicable

Regulating Emotions and Behaviors After Brain Injury

EncephalitisAcquired Brain InjuryMeningitis+3 more
University Hospital, Strasbourg, France77 enrolled1 locationNCT05393492
Recruiting

Fungal Infection Susceptibility

Cryptococcal MeningitisCryptococcosisCryptococcal Infection+2 more
National Institute of Allergy and Infectious Diseases (NIAID)800 enrolled1 locationNCT00001352
Recruiting
Phase 2

Trial of a Six-Month Regimen of High-Dose Rifampicin, High-Dose Isoniazid, Linezolid, and Pyrazinamide Versus a Standard Nine-Month Regimen for the Treatment of Adults and Adolescents With Tuberculous Meningitis

Tuberculous Meningitis
National Institute of Allergy and Infectious Diseases (NIAID)330 enrolled18 locationsNCT05383742
Recruiting

Recovery Trajectory for Coma and Disorders of Consciousness

Traumatic Brain InjuriescomaDisorders of Consciousness+5 more
University of California, San Francisco2,000 enrolled1 locationNCT07614074
Recruiting
Phase 2

Adjunctive Doxycycline for Central Nervous System Tuberculosis

Tuberculosis, MeningealTuberculosis; Meningitis (Etiology)Tuberculosis, Central Nervous System+1 more
National University Hospital, Singapore200 enrolled6 locationsNCT06446245
Recruiting

Acute Treatment and Long-term Assessment of Adult Infectious Meningitis

MeningitisBacterial MeningitisViral Meningitis+1 more
Hospital Israelita Albert Einstein624 enrolled3 locationsNCT07027475
Recruiting

Prospective Clinical Registry of Acute Treatment and Long-term Assessment of Children Meningitis

Bacterial InfectionsMeningitisViral Meningitis+1 more
Hospital Israelita Albert Einstein600 enrolled1 locationNCT07062445
Recruiting
Phase 2Phase 3

Single Dose Liposomal Amphotericin for Asymptomatic Cryptococcal Antigenemia

Cryptococcal Meningitis
Makerere University356 enrolled1 locationNCT03945448
Recruiting

National Bacterial Meningitis Study in Children and Newborns

MeningitisChildren, OnlyNeonatal Infection+5 more
Association Clinique Thérapeutique Infantile du val de Marne10,000 enrolled1 locationNCT04664569
Recruiting

Febrile Infants Swedish Study

Serious Bacterial InfectionSepsisBacteremia+4 more
Region Skane2,000 enrolled11 locationsNCT07134751
Recruiting

Augmented Renal Clearance in Neurocritical Care

Ischemic StrokeIntracerebral HemorrhageTBI (Traumatic Brain Injury)+4 more
University of Alberta512 enrolled3 locationsNCT07410624
Recruiting
Not Applicable

The Use of an Audio-visual Method in Counseling for Pediatric Lumbar Puncture Procedure

Meningitis in Children
Oman Ministry of Health154 enrolled1 locationNCT07409220
Recruiting
Phase 2Phase 3

A Follow-up Trial of GBS-NN/NN2 Vaccine in Healthy Pregnant Women

Neonatal SepsisPneumoniaInfections+6 more
Minervax ApS338 enrolled6 locationsNCT06592586
Recruiting
Phase 4

Investigating Gender and Sex Differences in Immune Responses Through Vaccination of Transgender and Cisgender Persons

VaccinationTransgender PersonsMeningococcal Meningitis, Serogroup B+1 more
University Ghent250 enrolled1 locationNCT06832514
Recruiting

Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective

Streptococcus PneumoniaeMalariaMeningitis+55 more
Institut Pasteur du Cambodge10,000 enrolled1 locationNCT07358910
Recruiting

Optic Nerve Ultrasound for Assessing Cerebral Inflammation and Intracranial Hypertension in Cerebral Pathologies

UltrasoundStrokeMeningitis/Encephalitis+3 more
Spitalul Clinic de Boli Infecțioase și tropicale "Dr. Victor Babeș"200 enrolled2 locationsNCT07332234
Recruiting
Not Applicable

Meningitis: Burden, Causes, Screening and Prevention in Rural Northern Uganda

Meningitis
University of Rochester11,100 enrolled1 locationNCT05496673
Recruiting
Phase 2Phase 3

Platform Trial For Cryptococcal Meningitis

HIVCryptococcal Meningitis
University of Minnesota2,000 enrolled2 locationsNCT06666322
Recruiting
Phase 1

Clinical Trial of the Adsorbed Acellular Pertussis (Tricomponent) DTaP-Haemophilus Influenzae Type b (Conjugate)-ACYW135 Group Meningococcal (Conjugate) Combined Vaccine

Diphtheria, Tetanus and Acellular PertussisEpidemic MeningitisHaemophilus Influenzae Type B Infection
CanSino Biologics Inc.260 enrolled1 locationNCT07203755